NCT05605028

Brief Summary

The intervention will focus on identifying risk factors for depression and anxiety and will quantitate the educational component of the POWER Obesity group intervention delivered by mental health professionals that are currently presenting for 30 min during the Monday session to address the root causes of obesity as well as to encourage positive lifestyle changes (e.g. sleep, diet, sun exposure, circadian rhythms, and addictions). The previously published hypothesis identifies triggers, that combined, could cause mental health problems. The 10 groups of triggers are: (1) Genetic, (2) Developmental, (3) Lifestyle, (4) Circadian Rhythm, (5) Addiction, (6) Nutrition, (7) Toxic, (8) Social/Complicated Grief, (9) Medical Condition, and (10) Frontal Lobe. Each of these factors will be dealt with in the lifestyle intervention. The project will be led by the assistant professor (in process) Francisco E Ramirez, MD with his mentor Theodore Friedman, MD, PhD supervising the project. Hypothesis: The investigators hypothesize that composite POWER Obesity group will have greater improvement in mental health compared to the dietitian-led group. Measuring outcomes: The intervention will take 1 year to recruit all the patients the investigators expect to have the 75 patients in the group intervention and 25 patients in the dietitian-led group. With these numbers, our preliminary power analysis suggests there will be a difference in the two groups with an alpha of .05 and 80% power. The investigators will add 3 tests to both arms of the study, 9-question Patient Health Questionnaire (PQ-9), Generalized Anxiety Disorder (GAD), and the Depression and Anxiety Assessment Test, in the POWER Obesity group at 0, 3, 6 months and 12 months of intervention.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 3, 2022

Completed
10 months until next milestone

Study Start

First participant enrolled

September 2, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2025

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

April 1, 2024

Status Verified

March 1, 2024

Enrollment Period

2.3 years

First QC Date

October 18, 2022

Last Update Submit

March 28, 2024

Conditions

Outcome Measures

Primary Outcomes (12)

  • Patient Health Questionnaire (PQ-9) Test

    Measures depression using Patient Health Questionnaire (PQ-9). Total score ranges from 0 to 27. The higher the score means a worse outcome.

    Taken at baseline.

  • Patient Health Questionnaire (PQ-9) Test

    Measures depression using Patient Health Questionnaire (PQ-9). Total score ranges from 0 to 27. The higher the score means a worse outcome.

    Taken at 3 months of intervention

  • Patient Health Questionnaire (PQ-9) Test

    Measures depression using Patient Health Questionnaire (PQ-9). Total score ranges from 0 to 27. The higher the score means a worse outcome.

    Taken at 6 months of intervention

  • Patient Health Questionnaire (PQ-9) Test

    Measures depression using Patient Health Questionnaire (PQ-9). Total score ranges from 0 to 27. The higher the score means a worse outcome.

    Taken at 12 months of intervention

  • Generalized Anxiety Disorder (GAD-7) Test

    Measures depression using the Generalized Anxiety Disorder (GAD-7). Total score ranges from 0 to 21. The higher the score means a worse outcome.

    Taken at baseline

  • Generalized Anxiety Disorder (GAD-7) Test

    Measures depression using the Generalized Anxiety Disorder (GAD-7). Total score ranges from 0 to 21. The higher the score means a worse outcome.

    Taken at 3 months of intervention

  • Generalized Anxiety Disorder (GAD-7) Test

    Measures depression using the Generalized Anxiety Disorder (GAD-7). Total score ranges from 0 to 21. The higher the score means a worse outcome.

    Taken at 6 months of intervention

  • Generalized Anxiety Disorder (GAD-7) Test

    Measures depression using the Generalized Anxiety Disorder (GAD-7). Total score ranges from 0 to 21. The higher the score means a worse outcome.

    Taken at 12 months of intervention

  • Depression and Anxiety Assessment Test

    Measures depression and causes of depression using the Depression and Anxiety . Assessment Test. It reports which of 10 possible triggers of depression the patient has at the moment the test was taken. The text triggers are: Genetic, Developmental, Lifestyle, Circadian Rhythm, Addiction, Nutrition, Toxic, Social/Complicated Grief, Medical Condition, and Frontal Lobe.

    Taken at baseline

  • Depression and Anxiety Assessment Test

    Measures depression and causes of depression using the Depression and Anxiety . Assessment Test. It reports which of 10 possible triggers of depression the patient has at the moment the test was taken. The text triggers are: Genetic, Developmental, Lifestyle, Circadian Rhythm, Addiction, Nutrition, Toxic, Social/Complicated Grief, Medical Condition, and Frontal Lobe.

    Taken at 3 months of intervention

  • Depression and Anxiety Assessment Test

    Measures depression and causes of depression using the Depression and Anxiety . Assessment Test. It reports which of 10 possible triggers of depression the patient has at the moment the test was taken. The text triggers are: Genetic, Developmental, Lifestyle, Circadian Rhythm, Addiction, Nutrition, Toxic, Social/Complicated Grief, Medical Condition, and Frontal Lobe.

    Taken at 6 months of intervention

  • Depression and Anxiety Assessment Test

    Measures depression and causes of depression using the Depression and Anxiety . Assessment Test. It reports which of 10 possible triggers of depression the patient has at the moment the test was taken. The text triggers are: Genetic, Developmental, Lifestyle, Circadian Rhythm, Addiction, Nutrition, Toxic, Social/Complicated Grief, Medical Condition, and Frontal Lobe.

    Taken at 12 months of intervention

Study Arms (2)

Mental Health lifestyle intervention

EXPERIMENTAL

The intervention will focus on identifying risk factors for depression and anxiety and will quantitate the educational component of the POWER Obesity group intervention delivered by mental health professionals that are currently presenting for 30 min during the Monday session to address the root causes of obesity as well as to encourage positive lifestyle changes (e.g. sleep, diet, sun exposure, circadian rhythms, and addictions). The previously published hypothesis identifies triggers, that combined, could cause mental health problems. The 10 groups of triggers are: (1) Genetic, (2) Developmental, (3) Lifestyle, (4) Circadian Rhythm, (5) Addiction, (6) Nutrition, (7) Toxic, (8) Social/Complicated Grief, (9) Medical Condition, and (10) Frontal Lobe. Each of these factors will be dealt with in the lifestyle intervention.

Behavioral: Mental Health lifestyle intervention

Dietitian-led

ACTIVE COMPARATOR

A group of participants that visit a dietitian will be the control.

Other: Dietitian-led

Interventions

The focus is to identify 10 potential groups of causes and working on reversing them. The 10 factors are: (1) Genetic, (2) Developmental, (3) Lifestyle, (4) Circadian Rhythm, (5) Addiction, (6) Nutrition, (7) Toxic, (8) Social/Complicated Grief, (9) Medical Condition, and (10) Frontal Lobe. Each of these factors will be dealt with in the lifestyle intervention.

Also known as: 10 hit hypothesis intervention
Mental Health lifestyle intervention

A group of people that visit the dietitian will be used as comparison against the Mental Health lifestyle intervention

Dietitian-led

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must be 18 or older,
  • BMI \> 30 kg/m2
  • Open to either being part of a group visit or being coached by a dietitian.
  • Must be currently receiving care at LAC-DHS or be eligible for this care and be enrolled in a primary care provider (PCP) capable of adjusting their medicines, including anti-hypertensive and diabetic medications,
  • It is not necessary to have diabetes or hypertension in addition to obesity to enroll.

You may not qualify if:

  • Currently participating of an obesity treatment program
  • Currently taking weight loss medications such as orlistat, lorcaserin, phentermine/topiramate-ER, phenetermine, diethylpropion, phendimetrazine, and benzphetamine They can enroll if they have stopped taking weight loss medicine for at least two months.
  • Those actively suicidal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Nedley N, Ramirez FE. Nedley Depression Hit Hypothesis: Identifying Depression and Its Causes. Am J Lifestyle Med. 2016 Nov;10(6):422-428. doi: 10.1177/1559827614550779. Epub 2014 Nov 10.

    PMID: 27885322BACKGROUND

MeSH Terms

Conditions

DepressionAnxiety DisordersSedentary BehaviorObesityMalnutrition

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The intervention will take 1 year to recruit all the patients. The investigators expect to have the 75 patients in the group intervention and 25 patients in the dietitian-led group. With these numbers, our preliminary power analysis suggests there will be a difference in the two groups with an alpha of .05 and 80% power. The investigators will add 3 tests to both arms of the study, 9-question Patient Health Questionnaire (PQ-9), Generalized Anxiety Disorder (GAD), and the Depression and Anxiety Assessment Test, in the POWER Obesity group at 0, 3, 6 months and 12 months of intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

October 18, 2022

First Posted

November 3, 2022

Study Start

September 2, 2023

Primary Completion

December 2, 2025

Study Completion

December 30, 2025

Last Updated

April 1, 2024

Record last verified: 2024-03